WHO ICTRP trial
Insulin signal peptide, a novel measure of pancreatic insulin synthesis and…
ACTRN12612001198819 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12612001198819 |
|---|---|
| Public title | Insulin signal peptide, a novel measure of pancreatic insulin synthesis and production |
| Scientific title | A study to assess insulin signal peptide (INSsp) as a measure of pancreatic beta islet cell function and mass through clinical studies of blood samples from donors including thoose who are healthy, pre-diabetic and with Type 1 and Type 2 diabetes mellitus |
| Primary sponsor | Ministry of Business, Innovation & Employment |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Phase | Not Applicable |
| Countries | New Zealand |
| Conditions | diabetes mellitus;Insulin signal peptide, a novel measure of pancreatic insulin synthesis and production; diabetes mellitus Insulin signal peptide, a novel measure of pancreatic insulin synthesis and production;Metabolic and Endocrine… |
| Interventions | 5 groups of participants will be invited to take part in this study: 1. 100 normal, healthy volunteers (50 men, 50 woman) aged between 20-70 2. 70 female patients referred for glucose load testing in the first trimester of pregnancy. 3. 50… |
| Registration date | Nov 14, 2012 |
| Target size | 320 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: